OncoZenge AB (publ) (STO:ONCOZ)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.660
-0.160 (-4.19%)
Sep 4, 2026, 12:49 PM CET

OncoZenge AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.972.7800--
Revenue Growth
114.78%278300.00%-66.67%---
Gross Profit
5.972.7800--
Operating Income
-25.66-15.79-8.69-15.9-20.4-4.89
Net Income
-26.17-15.94-8.69-15.9-46.65-3.89
Earnings Per Share
-2.00-1.31-0.74-1.36-3.98-0.33
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.753.713.8612.6329.1451.22
Total Debt
7.57.5----
Net Cash (Debt)
-6.75-3.793.8612.6329.1451.22
Net Cash Growth
---69.41%-56.67%-43.11%412.23%
Net Cash Per Share
-0.52-0.310.331.082.494.35

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.79-13.06-8.76-17.08-22.08-4.77
Free Cash Flow
-23.79-13.06-8.76-17.08-22.08-4.77
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-429.58%-567.06%-868500.00%-530066.67%--
Pretax Margin
-438.07%-572.56%-868800.00%-530066.67%--
Profit Margin
-438.07%-572.56%-868800.00%-530066.67%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.4830.7143924.6712064.64--